SARS-CoV-2 Infection and the COVID-19 Pandemic Emergency: The Importance of Diagnostic Methods

被引:17
作者
Ciotti, Marco [1 ]
Benedetti, Francesca [2 ]
Zella, Davide [2 ]
Angeletti, Silvia [3 ]
Ciccozzi, Massimo [4 ]
Bernardini, Sergio [5 ,6 ]
机构
[1] Polyclin Tor Vergata Fdn, Lab Clin Microbiol & Virol, Virol Unit, Viale Oxford 81, IT-00133 Rome, Italy
[2] Univ Maryland, Sch Med, Inst Human Virol, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
[3] Univ Campus Biomed Rome, Unit Clin Lab Sci, Rome, Italy
[4] Univ Campus Biomed Rome, Unit Med Stat & Mol Epidemiol, Rome, Italy
[5] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[6] Polyclin Tor Vergata Fdn, Dept Lab Med, Rome, Italy
关键词
Coronavirus disease 2019; Severe acute respiratory syndrome coronavirus 2; Pandemic; Real-time PCR; Serology; Antigen test; CORONAVIRUS; IGA;
D O I
10.1159/000515343
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Currently, a pandemic of coronavirus disease 2019 (COVID-19) caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is underway, resulting in high morbidity and mortality across the globe. Summary: A prompt and effective diagnosis is crucial to identify infected individuals, to monitor the infection, to perform contact tracing, and to limit the spread of the virus. Since the announcement of this public health emergency, several diagnostic methods have been developed including molecular and serological assays, and more recently biosensors. Here, we present the use of these assays as well as their main technical features, advantages, and limits. Key Messages: The development of reliable diagnostic assays is crucial not only for a correct diagnosis and containment of COVID-19 pandemic, but also for the decision-making process that is behind the clinical decisions, eventually contributing to the improvement of patient management. Furthermore, with the advent of vaccine and therapeutic monoclonal antibodies against SARS-CoV-2, serological assays will be instrumental for the validation of these new therapeutic options.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 32 条
[1]   Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases [J].
Ai, Tao ;
Yang, Zhenlu ;
Hou, Hongyan ;
Zhan, Chenao ;
Chen, Chong ;
Lv, Wenzhi ;
Tao, Qian ;
Sun, Ziyong ;
Xia, Liming .
RADIOLOGY, 2020, 296 (02) :E32-E40
[2]  
[Anonymous], 2020, SARS COV 2 ANTIGEN D
[3]   CRISPR-Cas12-based detection of SARS-CoV-2 [J].
Broughton, James P. ;
Deng, Xianding ;
Yu, Guixia ;
Fasching, Clare L. ;
Servellita, Venice ;
Singh, Jasmeet ;
Miao, Xin ;
Streithorst, Jessica A. ;
Granados, Andrea ;
Sotomayor-Gonzalez, Alicia ;
Zorn, Kelsey ;
Gopez, Allan ;
Hsu, Elaine ;
Gu, Wei ;
Miller, Steve ;
Pan, Chao-Yang ;
Guevara, Hugo ;
Wadford, Debra A. ;
Chen, Janice S. ;
Chiu, Charles Y. .
NATURE BIOTECHNOLOGY, 2020, 38 (07) :870-+
[4]   Antibody tests for identification of current and past infection with SARS-CoV-2 [J].
Deeks, Jonathan J. ;
Dinnes, Jacqueline ;
Takwoingil, Yemisi ;
Davenport, Clare ;
Spijker, Ren ;
Taylor-Phillips, Sian ;
Adrianol, Ada ;
Beesel, Sophie ;
Dretzkel, Janine ;
di Ruffanol, Lavinia Ferrante ;
Harris, Isobel M. ;
Price, Malcolm J. ;
Dittrich, Sabine ;
Emperador, Devy ;
Hooft, Lotty ;
Leeflang, Mariska M. G. ;
Van den Bruel, Ann .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06)
[5]   Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial [J].
Folegatti, Pedro M. ;
Ewer, Katie J. ;
Aley, Parvinder K. ;
Angus, Brian ;
Becker, Stephan ;
Belij-Rammerstorfer, Sandra ;
Bellamy, Duncan ;
Bibi, Sagida ;
Bittaye, Mustapha ;
Clutterbuck, Elizabeth A. ;
Dold, Christina ;
Faust, Saul N. ;
Finn, Adam ;
Flaxman, Amy L. ;
Hallis, Bassam ;
Heath, Paul ;
Jenkin, Daniel ;
Lazarus, Rajeka ;
Makinson, Rebecca ;
Minassian, Angela M. ;
Pollock, Katrina M. ;
Ramasamy, Maheshi ;
Robinson, Hannah ;
Snape, Matthew ;
Tarrant, Richard ;
Voysey, Merryn ;
Green, Catherine ;
Douglas, Alexander D. ;
Hill, Adrian V. S. ;
Lambe, Teresa ;
Gilbert, Sarah C. ;
Pollard, Andrew J. .
LANCET, 2020, 396 (10249) :467-478
[6]   COVID-19 vaccine design: the Janus face of immune enhancement [J].
Hotez, Peter J. ;
Corry, David B. ;
Bottazzi, Maria Elena .
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (06) :347-348
[7]   Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J].
Huang, Chaolin ;
Wang, Yeming ;
Li, Xingwang ;
Ren, Lili ;
Zhao, Jianping ;
Hu, Yi ;
Zhang, Li ;
Fan, Guohui ;
Xu, Jiuyang ;
Gu, Xiaoying ;
Cheng, Zhenshun ;
Yu, Ting ;
Xia, Jiaan ;
Wei, Yuan ;
Wu, Wenjuan ;
Xie, Xuelei ;
Yin, Wen ;
Li, Hui ;
Liu, Min ;
Xiao, Yan ;
Gao, Hong ;
Guo, Li ;
Xie, Jungang ;
Wang, Guangfa ;
Jiang, Rongmeng ;
Gao, Zhancheng ;
Jin, Qi ;
Wang, Jianwei ;
Cao, Bin .
LANCET, 2020, 395 (10223) :497-506
[8]   Use of Chest CT in Combination with Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical Suspicion [J].
Huang, Peikai ;
Liu, Tianzhu ;
Huang, Lesheng ;
Liu, Hailong ;
Lei, Ming ;
Xu, Wangdong ;
Hu, Xiaolu ;
Chen, Jun ;
Liu, Bo .
RADIOLOGY, 2020, 295 (01) :22-23
[9]   Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples [J].
Jaaskelainen, Anne J. ;
Kekalainen, Eliisa ;
Kallio-Kokko, Hannimari ;
Mannonen, Laura ;
Kortela, Elisa ;
Vapalahti, Olli ;
Kurkela, Satu ;
Lappalainen, Maija .
EUROSURVEILLANCE, 2020, 25 (18) :11-18
[10]   Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing [J].
Joung, Julia ;
Ladha, Alim ;
Saito, Makoto ;
Kim, Nam-Gyun ;
Woolley, Ann E. ;
Segel, Michael ;
Barretto, Robert P. J. ;
Ranu, Amardeep ;
Macrae, Rhiannon K. ;
Faure, Guilhem ;
Ioannidi, Eleonora I. ;
Krajeski, Rohan N. ;
Bruneau, Robert ;
Huang, Meei-Li W. ;
Yu, Xu G. ;
Li, Jonathan Z. ;
Walker, Bruce D. ;
Hung, Deborah T. ;
Greninger, Alexander L. ;
Jerome, Keith R. ;
Gootenberg, Jonathan S. ;
Abudayyeh, Omar O. ;
Zhang, Feng .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1492-+